Phase 3 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 3 and 79 years old
- You are able to carry out basic daily activities and care for yourself (your doctor will assess this using a standard scale)
- You have had a stem cell transplant and tests have shown a small number of abnormal B cells (a type of immune cell) still present in your body, suggesting the disease may return
- Your disease has not come back in your blood or in other parts of your body outside the bone marrow
- Your organs (such as your liver and kidneys) are working well enough to take part
- If you are a woman who could become pregnant, you must have a negative pregnancy test
Who may not be able to join:
- You currently have an active infection of any kind
- You have graft-versus-host disease (a complication of stem cell transplants where donor cells attack your body) that is not under control
- You have a history of disorders affecting the brain or nervous system
- You have an autoimmune disease (a condition where your immune system attacks your own body)
- You currently have another type of cancer that is active
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8610-88326900
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3-month MRD negativity rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.